Literature DB >> 16964553

Polymorphisms in the repeat long regions of oncogenic and attenuated pathotypes of Marek's disease virus 1.

Stephen J Spatz1, Robert F Silva.   

Abstract

The nucleotide sequences of the terminal repeat long (TR(L)) and internal repeat long regions (IR(L)) in the genomes of 13 strains of Marek's disease virus type 1 (MDV-1) were determined and represent the largest collection of sequencing data from a contiguous region (12.8 kb) in the serotype 1 genomes. The collection of strains used in this study has been well characterized with respect to their virulence and contains members of each pathotype (4 attenuated, 1 mildly virulent, 3 virulent, 2 very virulent and 3 very virulent plus). It has previously been reported that two loci (meq and RLORF4) in the RL regions are likely to encode virulence factors based on comparative genomic studies involving vaccine and virulent strains. Additional studies using knockout mutants have provided stronger evidence that indeed RLORF4 and meq or the overlapping genes 23 kD and RLORF6 are involved in virulence. In this report, we provide evidence that additional open reading frames (ORFs) in the RL regions differ significantly between the extremes of the pathotypes (attenuated vs. nonattenuated). A deletion of 10 base pairs has been identified in RLORF12 from two attenuated strains CVI988 BP-5, p48 and RM-1, p40; and the lower virulence strain JM/102W. A deletion of 40 bp was also identified in RLORF4 of the attenuated strain R2/23, passage 106. A 177 bp insertion within the meq loci has been identified in most of the attenuated strains examined. Interestingly, R2/23 did not contain this insertion but instead truncated proteins are predicted for the three overlapping ORFs (meq, 23 kD and RLORF6) due to a frameshift mutation. Single nucleotide polymorphisms (SNPs), which loosely partition between attenuated and nonattenuated strains, have been identified in the ORFs encoding RLORF12, RLORF8, meq, 23 kD, RLORF6, RLORF4, RLORF3 and ICP0 and three previously unidentified short ORFs: MHLS, MLHG and MPSG. Although no single nucleotide polymorphism in the RL regions could predict virulence, their overall contribution to virulence can now be examined in defined mutants containing additional insertions or deletions in ORFs, suspected of encoding virulence factors, identified by this research.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16964553     DOI: 10.1007/s11262-006-0024-5

Source DB:  PubMed          Journal:  Virus Genes        ISSN: 0920-8569            Impact factor:   2.198


  51 in total

1.  The role of repetitive DNA sequences in the size variation of Epstein-Barr virus (EBV) nuclear antigens, and the identification of different EBV isolates using RFLP and PCR analysis.

Authors:  K Falk; J W Gratama; M Rowe; J Z Zou; F Khanim; L S Young; M A Oosterveer; I Ernberg
Journal:  J Gen Virol       Date:  1995-04       Impact factor: 3.891

2.  Multiple sequence alignment with hierarchical clustering.

Authors:  F Corpet
Journal:  Nucleic Acids Res       Date:  1988-11-25       Impact factor: 16.971

3.  Amplification of a tandem direct repeat within inverted repeats of Marek's disease virus DNA during serial in vitro passage.

Authors:  K Maotani; A Kanamori; K Ikuta; S Ueda; S Kato; K Hirai
Journal:  J Virol       Date:  1986-05       Impact factor: 5.103

4.  Tandem repeated DNA in an intergenic region of herpes simplex virus type 1 (Patton).

Authors:  K Umene; R J Watson; L W Enquist
Journal:  Gene       Date:  1984-10       Impact factor: 3.688

5.  Characterization of human cytomegalovirus strains by analysis of short tandem repeat polymorphisms.

Authors:  A Walker; S J Petheram; L Ballard; J R Murph; G J Demmler; J F Bale
Journal:  J Clin Microbiol       Date:  2001-06       Impact factor: 5.948

6.  Increased virulence of Marek's disease virus field isolates.

Authors:  R L Witter
Journal:  Avian Dis       Date:  1997 Jan-Mar       Impact factor: 1.577

7.  Characterization of the protein product encoded by a splicing variant of the Marek's disease virus Eco-Q gene (Meq).

Authors:  Q Peng; Y Shirazi
Journal:  Virology       Date:  1996-12-01       Impact factor: 3.616

8.  Translationally controlled tumor protein is a target of tumor reversion.

Authors:  Marcel Tuynder; Giusy Fiucci; Sylvie Prieur; Alexandra Lespagnol; Anne Géant; Séverine Beaucourt; Dominique Duflaut; Stéphanie Besse; Laurent Susini; Jean Cavarelli; Dino Moras; Robert Amson; Adam Telerman
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-15       Impact factor: 11.205

9.  Comparative analysis of Marek's disease virus (MDV) glycoprotein-, lytic antigen pp38- and transformation antigen Meq-encoding genes: association of meq mutations with MDVs of high virulence.

Authors:  Christine E Shamblin; Natalie Greene; Vaithilingaraja Arumugaswami; Robert L Dienglewicz; Mark S Parcells
Journal:  Vet Microbiol       Date:  2004-09-08       Impact factor: 3.293

10.  A virus-encoded telomerase RNA promotes malignant T cell lymphomagenesis.

Authors:  Sascha Trapp; Mark S Parcells; Jeremy P Kamil; Daniel Schumacher; B Karsten Tischer; Pankaj M Kumar; Venugopal K Nair; Nikolaus Osterrieder
Journal:  J Exp Med       Date:  2006-05-01       Impact factor: 14.307

View more
  19 in total

1.  Comparative sequence analysis of a highly oncogenic but horizontal spread-defective clone of Marek's disease virus.

Authors:  Stephen J Spatz; Yuguang Zhao; Lawrence Petherbridge; Lorraine P Smith; Susan J Baigent; Venugopal Nair
Journal:  Virus Genes       Date:  2007-08-25       Impact factor: 2.332

2.  Characterization of a Gallid herpesvirus 2 strain with novel reticuloendotheliosis virus long terminal repeat inserts.

Authors:  Yan-Ping Zhang; Ke-Yan Bao; Guo-Rong Sun; Hong-Chao Lv; Hong-Yu Cui; Yu-Long Gao; Xiao-Mei Wang; Chang-Jun Liu
Journal:  Virus Genes       Date:  2017-02-13       Impact factor: 2.332

3.  Clustering of mutations within the inverted repeat regions of a serially passaged attenuated gallid herpesvirus type 2 strain.

Authors:  Stephen J Spatz; Cary Rue; Daniel Schumacher; Nikolaus Osterrieder
Journal:  Virus Genes       Date:  2008-05-31       Impact factor: 2.332

4.  Genome sequence determination and analysis of a Chinese virulent strain, LMS, of Gallid herpesvirus type 2.

Authors:  Yun Cheng; Feng Cong; Yan-ping Zhang; Zhi-jie Li; Na-na Xu; Guang-yu Hou; Chang-Jun Liu
Journal:  Virus Genes       Date:  2012-04-04       Impact factor: 2.332

5.  A p53-dependent promoter associated with polymorphic tandem repeats controls the expression of a viral transcript encoding clustered microRNAs.

Authors:  Grégoire Stik; Sylvie Laurent; Damien Coupeau; Baptiste Coutaud; Ginette Dambrine; Denis Rasschaert; Benoît Muylkens
Journal:  RNA       Date:  2010-09-29       Impact factor: 4.942

6.  Comparative genomic sequence analysis of the Marek's disease vaccine strain SB-1.

Authors:  Stephen J Spatz; Karel A Schat
Journal:  Virus Genes       Date:  2011-02-20       Impact factor: 2.332

7.  Molecular and pathogenicity characterization of Gallid herpesvirus 2 newly isolated in China from 2009 to 2013.

Authors:  Yan-Ping Zhang; Hong-Chao Lv; Ke-Yan Bao; Yu-Long Gao; Hong-Lei Gao; Xiao- le Qi; Hong-Yu Cui; Yong-Qiang Wang; Kai Li; Li Gao; Xiao-Mei Wang; Chang-Jun Liu
Journal:  Virus Genes       Date:  2015-11-26       Impact factor: 2.332

8.  Sequence determination of a mildly virulent strain (CU-2) of Gallid herpesvirus type 2 using 454 pyrosequencing.

Authors:  Stephen J Spatz; Cary A Rue
Journal:  Virus Genes       Date:  2008-03-20       Impact factor: 2.332

9.  Phylogeny and recombination history of gallid herpesvirus 2 (Marek's disease virus) genomes.

Authors:  Austin L Hughes; Pierre Rivailler
Journal:  Virus Res       Date:  2007-06-12       Impact factor: 3.303

10.  Dynamic equilibrium of Marek's disease genomes during in vitro serial passage.

Authors:  Stephen J Spatz; Jeremy D Volkening; Isabel M Gimeno; Mohammad Heidari; Richard L Witter
Journal:  Virus Genes       Date:  2012-08-26       Impact factor: 2.332

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.